论文部分内容阅读
2015年1月8日,泸州市科知局组织专家对四川科瑞德凯华制药有限公司完成的“盐酸噻加宾原料药工艺开发”项目进行了科技成果鉴定。专家们先后查看了生产车间,听取了项目汇报,审阅了相关资料,经过质询、讨论,认为该项目在主要工艺技术创新方面,工艺路线设计合理、可靠,采用特殊的后处理工艺,缩短了生产周期,降低了生产成本,将精制收率提高至90%以上,同时保证了99.9%的化学纯度和光学纯度,各项技术、质量指标均达到美国UCP35标准要
On January 8, 2015, Luzhou Bureau of Science, Technology and Knowledge Organization organized experts to appraise the scientific and technological achievements of the project of “Tiagabine Hydrochloride API Development” which was completed by Sichuan Kerui De Kaihua Pharmaceutical Co., Ltd. The experts successively reviewed the production workshop, listened to the project reports, reviewed the relevant materials, and after inquiring and discussing, considered that the process design was reasonable and reliable in terms of major technological innovation, and the special post-treatment process was adopted to shorten the production Cycle, reducing production costs, the refining yield increased to 90% or more, while ensuring 99.9% of the chemical purity and optical purity, the technical, quality indicators have reached the United States UCP35 standards